Literature DB >> 22935011

Risk factor assessment for problematic use of opioids for chronic pain.

Robert N Jamison1, Robert R Edwards.   

Abstract

Opioid analgesics provide effective treatment for noncancer pain, but many health providers have concerns about cognitive effects, tolerance, dependence, and addiction. Misuse of opioids is prominent in patients with chronic pain and early recognition of misuse risk could help providers offer adequate patient care while implementing appropriate levels of monitoring to reduce aberrant drug-related behaviors. Many persons with chronic pain also have significant medical and psychiatric comorbidities that affect treatment decisions. Neuropsychologists can play an important role in the identification of psychological and social dysfunction and in matching personal characteristics to effective interventions as part of a multidisciplinary approach to pain management. The assessment of different domains using semi-structured interviews, sensory and neuropsychological testing, and standardized self-report measures permits identification of somatosensory, emotional, cognitive, behavioral, and social issues in order to facilitate treatment planning. In this review we discuss opioid abuse and misuse issues that often arise in the treatment of patients with chronic pain, and present an overview of assessment and treatment strategies that can be effective in improving outcomes associated with the use of prescription opioids for pain. Finally we briefly discuss the effect of opiate analgesics on cognition and review some intervention strategies for chronic pain patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22935011     DOI: 10.1080/13854046.2012.715204

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  11 in total

1.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

2.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

3.  Factors associated with prescription opioid misuse in adults aged 50 or older.

Authors:  Yu-Ping Chang
Journal:  Nurs Outlook       Date:  2017-11-29       Impact factor: 3.250

4.  Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.

Authors:  Shiwei Steve Liu; Sarah Pickens; Nicole E Burma; Ines Ibarra-Lecue; Hongyan Yang; Lihua Xue; Chris Cook; Joshua K Hakimian; Amie L Severino; Lindsay Lueptow; Kristina Komarek; Anna M W Taylor; Mary C Olmstead; F Ivy Carroll; Caroline E Bass; Anne M Andrews; Wendy Walwyn; Tuan Trang; Christopher J Evans; Frances M Leslie; Catherine M Cahill
Journal:  J Neurosci       Date:  2019-03-12       Impact factor: 6.167

5.  Transcranial Direct Current Stimulation for Affective Symptoms and Functioning in Chronic Low Back Pain: A Pilot Double-Blinded, Randomized, Placebo-Controlled Trial.

Authors:  Timothy Y Mariano; Frederick W Burgess; Marguerite Bowker; Jason Kirschner; Mascha Van't Wout-Frank; Richard N Jones; Christopher W Halladay; Michael Stein; Benjamin D Greenberg
Journal:  Pain Med       Date:  2019-06-01       Impact factor: 3.750

6.  Validation of a brief Opioid Compliance Checklist for patients with chronic pain.

Authors:  Robert N Jamison; Marc O Martel; Robert R Edwards; Jing Qian; Kerry Anne Sheehan; Edgar L Ross
Journal:  J Pain       Date:  2014-08-01       Impact factor: 5.820

Review 7.  Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation.

Authors:  M Camilleri; D A Drossman; G Becker; L R Webster; A N Davies; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2014-08-28       Impact factor: 3.598

8.  Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.

Authors:  Catherine M Cahill; Lindsay Lueptow; Hannah Kim; Raj Shusharla; Amy Bishop; Christopher J Evans
Journal:  Handb Exp Pharmacol       Date:  2022

Review 9.  Comparison of the Impacts of Under-Treated Pain and Opioid Pain Medication on Cognitive Impairment.

Authors:  Sung Eun Jang; Ylisabyth S Bradshaw; Daniel B Carr
Journal:  Cureus       Date:  2022-02-08

10.  The Netrin-1 receptor DCC is a regulator of maladaptive responses to chronic morphine administration.

Authors:  De-Yong Liang; Ming Zheng; Yuan Sun; Peyman Sahbaie; Sarah A Low; Gary Peltz; Grégory Scherrer; Cecilia Flores; J David Clark
Journal:  BMC Genomics       Date:  2014-05-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.